Forty rare disease cases received new diagnoses through OpenAI technology at Boston Children’s Hospital. The system reduces operational burdens for clinicians while accelerating patient care. This application demonstrates a concrete shift from general LLM use to specialized clinical diagnostics. Practitioners can now leverage these tools to identify previously elusive genetic conditions.